Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
L. I. Zharikova
Observed names:
L. Zharikova,
Liudmila Zharikova,
Жарикова Л. И.,
Л И Жарикова
Institutions:
Pirogov Russian National Research Medical University,
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
Observed institutions:
Pirogov Russian National Research Medical University,
Ministry of Health of the Russian Federation,
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
ORCID:
0000-0002-1105-8676
Observed ORCID:
0000-0002-1105-8676
OpenAlex ID:
A5061421398
A simple algorithm with one flow cytometric MRD measurement identifies more than 40% of children with ALL who can be cured with low-intensity therapy. The ALL-MB 2008 trial results
2022
·
Alexander Popov
, Guenter Henze
, et al.
·
Leukemia
·
18
Blinatumomab as postremission therapy replaces consolidation and substantial parts of maintenance chemotherapy and results in stable MRD negativity in children with newly diagnosed B-lineage ALL
2024
·
Ekaterina Mikhailova
, Alexander Popov
, et al.
·
Journal for ImmunoTherapy of Cancer
·
16
One-point flow cytometric MRD measurement to identify children with excellent outcome after intermediate-risk BCP-ALL: results of the ALL-MB 2008 study
2022
·
Alexander Popov
, Guenter Henze
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
14
A simple procedure to identify children with B‐lineage acute lymphoblastic leukemia who can be successfully treated with low or moderate intensity: Sequential versus single‐point minimal residual disease measurement
2023
·
Alexander Popov
, Guenter Henze
, et al.
·
Pediatric Blood & Cancer
·
12
Strong expansion of normal CD19‐negative B‐cell precursors after the use of blinatumomab in the first‐line therapy of acute lymphoblastic leukaemia in children
2021
·
Ekaterina Mikhailova
, Julia Roumiantseva
, et al.
·
British Journal of Haematology
·
9
PDF
Flow cytometric MRD at the end of consolidation in childhood B-lineage acute lymphoblastic leukemia has significant prognostic value but limited clinical implications: Results of study ALL-MB 2008
2022
·
Alexander Popov
, Guenter Henze
, et al.
·
Leukemia Research
·
8
Deep veins thrombosis in children with blood diseases
2019
·
P. A. Zharkov
, D. S. Morozova
, et al.
·
Oncohematology
·
7
PDF
Treatment of acute lymphoblastic leukemia in adolescents and young adults: the experience of the Moscow–Berlin
2016
·
A. V. Pshonkin
, Yu. V. Rumyantseva
, et al.
·
Russian Journal of Pediatric Hematology and Oncology
·
7
PDF
A single flow cytometric MRD measurement in children with B-lineage acute lymphocytic leukemia and hyperleukocytosis redefines the requirements of high-risk treatment: Results of the study ALL-MB 2008
2022
·
Alexander Popov
, Guenter Henze
, et al.
·
Leukemia Research
·
6
Low-intensity therapy cures over 40 % of children with rapid Flow-MRD responding ALL: the ALL-MB 2008 trial results
2022
·
A. Popov
, G. Henze
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
6
PDF
Acute lymphoblastic leukemia in children with Down syndrome: comparative analysis of treatment results according to ALL-MB 2008 and ALL-MB 2015 protocols
2022
·
R. N. Suprun
, Yu. V. Rumyantseva
, et al.
·
Russian Journal of Pediatric Hematology and Oncology
·
5
PDF
Acute lymphoblastic leukemia in children with Down syndrome: “Moscow–Berlin” experience
2021
·
R. N. Suprun
, Yu. V. Roumiantseva
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
5
PDF
A hypodiploid karyotype in childhood B-cell precursor acute lymphoblastic leukemia
2021
·
Yu. V. Olshanskaya
, O. I. Soldatkina
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
4
PDF
Prognostic impact and clinical value of low levels of flow cytometric MRD at the end of induction in childhood B‐lineage acute lymphoblastic leukemia: Results of study ALL‐MB 2015
2025
·
Alexander Popov
, Guenter Henze
, et al.
·
HemaSphere
·
3
PDF
A Single Dose of PEG-Asparaginase at the Beginning of Induction Not Only Accelerates MRD Clearance but Also Improves Long-Term Outcome in Children with B-Lineage ALL
2023
·
Alexander Popov
, Günter Henze
, et al.
·
Cancers
·
3
PDF
Thromboses in children with acute lymphoblastic leukemia
2015
·
L. I. Zharikova
, Yu. V. Rumyantseva
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
3
Flow cytometric and cytomorphological definition of remission achievement in children with B-lineage acute lymphoblastic leukemia
2023
·
A. M. Popov
, G. A. Tsaur
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
2
PDF
Pegylated asparaginase during induction therapy in children with intermediate-risk acute lymphoblastic leukemia: results of a randomized study
2025
·
A. I. Karachunskiy
, S. N. Lagoyko
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
1
PDF
Flow cytometric minimal residual disease measurement accounting for cytogenetics in children with non‐high‐risk acute lymphoblastic leukemia treated according to the ALL‐MB 2008 protocol
2024
·
Alexander Popov
, Guenter Henze
, et al.
·
Cancer Medicine
·
1
PDF
Дифференцировочная терапия с использованием 13-цис-ретиноевой кислоты и низких доз цитозин-арабинозида у детей с ювенильным миеломоноцитарным лейкозом
2008
·
Л. А. Хачатрян
, Michael Maschan
, et al.
·
Oncohematology
·
1
Prognostic factors and long-term treatment outcomes in children with standard-risk acute lymphoblastic leukemia enrolled in the ALL-MB 2008 protocol: a retrospective analysis of 1,702 patients
2026
·
E. A. Tuesheva
, Yu. V. Rumyantseva
, et al.
·
Гематология и трансфузиология
PDF
THROMB-HEM study: detection of venous thrombosis depending on the type of underlying disease
2025
·
P. A. Zharkov
, D. A. Evstratov
, et al.
·
Russian Journal of Pediatric Hematology and Oncology
PDF
The use of blinatumomab in children with de novo Ph-negative B-lineage acute lymphoblastic leukemia and slow clearance of minimal residual disease
2024
·
A. M. Popov
, Yu. V. Rumyantseva
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
PDF
Bispecific monoclonal antibody blinatumomab in the first-line therapy of B-lineage acute lymphoblastic leukemia in children and adolescents: interim results of the Russian Ministry of Health approbation protocol
2024
·
A. I. Karachunskiy
, Yu. V. Rumyantseva
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
PDF
High-risk acute lymphoblastic leukemia in the ALL-MB 2002 study
2022
·
D. V. Litvinov
, N. V. Myakova
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
PDF
Show more works
View as search
Works count:
29
Citation count:
131
H-index:
7
I10-index:
4
Year
Topic
Type